Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma (Q43563145)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2001

edit

Language	Label	Description	Also known as
English	Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma	scientific article published in April 2001

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

title

Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

main subject

fluorouracil

1 reference

based on heuristic

inferred from title

author

Cancer and Leukemia Group B

series ordinal

6

object named as

Cancer and Leukemia Group B

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

author name string

N J Meropol

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

D Niedzwiecki

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

D Hollis

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

R L Schilsky

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

R J Mayer

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

published in

Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

volume

91

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

page(s)

1256-1263

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

cites work

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

5-Ethynyluracil (776C85): protection from 5-fluorouracil-induced neurotoxicity in dogs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

Oral fluoropyrimidines in the treatment of colorectal cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1256%3A%3AAID-CNCR1126%3E3.0.CO%3B2-V

retrieved

21 January 2018

Identifiers

DOI

10.1002/1097-0142(20010401)91:7<1256::AID-CNCR1126>3.0.CO;2-V

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

PubMed publication ID

11283924

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11283924

retrieved

24 November 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43563145&oldid=2101113352"